Prognosis

J&J Vaccine Protects Monkeys From Covid With Single Shot

  • Company anticipates approaching regulators with one-dose shot
  • One-shot regimen may tighten race with vaccines further along
U.S. Vaccine Put To Final Test
Lock
This article is for subscribers only.

Sign up here for our daily coronavirus newsletter on what you need to know, and subscribe to our Covid-19 podcast for the latest news and analysis.

Johnson & Johnson’s experimental coronavirus vaccine protected macaque monkeys with a single shot in a pre-clinical study, potentially gaining on other vaccines that are further along in testing but require two doses over time.